Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07207473 · ClinicalTrials.gov registry record · NA
Behavioral Optimization to Overcome Obstructive Sleep Apnea Treatment Barriers
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT07207473: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07207473 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07207473, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
Previous studies have shown that programs encouraging the use of OSA treatments can help patients use these treatments more often, but the improvement is usually modest. This trial will test if giving patients a decision-making tool when they are first diagnosed with OSA, and combining their responses from this tool into a supportive program, will improve sleep quality and help them use their treatment more regularly.
Primary Outcome
The PSQI total score will be used as a measurement of sleep quality. Scores range from 0 to 21. Higher scores indicate worse outcome.
Interventions
- BEHAVIORAL Behavioral strategy program X plus Y
- BEHAVIORAL Behavioral strategy program X
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2026-11-02 |
| Est. Completion | 2031-03-31 |
| Phase | NA |
What is known before NCT07207473 opens enrollment
NCT07207473 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral strategy program X plus Y is the first listed.
NCT07207473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07207473 about?
NCT07207473 is a clinical study titled "Behavioral Optimization to Overcome Obstructive Sleep Apnea Treatment Barriers". Previous studies have shown that programs encouraging the use of OSA treatments can help patients use these treatments more often, but the improvement is usually modest. This trial will test if giving patients a decision-making tool when they are first diagnosed with OSA, and combining their respons...
What is the current status of trial NCT07207473?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2026-11-02. Estimated completion is 2031-03-31.
What interventions are being tested in trial NCT07207473?
The interventions under investigation include: Behavioral strategy program X plus Y (BEHAVIORAL), Behavioral strategy program X (BEHAVIORAL).
Who is sponsoring clinical trial NCT07207473?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07207473's enrollment target sits among peer trials
128 744th of 2000 higher than 1,252 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI